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EDITORIALLong-term Results of OVER: The Dream of EVAR is Not OverThe recent release of results from long-term comparison of
endovascular and open repair of abdominal aortic aneu-
rysms (AAAs) by the Open versus Endovascular Repair
(OVER) Veterans Affairs Study1 and the related commentary
by Dr. Beckman2 might raise in the audience different views
towards endovascular aortic repair (EVAR). Despite the
OVER Authors seeming somewhat worried about the risk of
delayed rupture after EVAR and the limited beneﬁt of the
procedure for patients over 70 years of age, the results they
found indeed support the long-term beneﬁt of EVAR. It
should be also noted that since when the OVER patients
have been randomised a decade has passed. During this
decade, device design has evolved, physician practices have
changed with surgeons being more exposed and proﬁcient
in EVAR and less exposed to open surgery and imaging
equipment has advanced. It is reasonable to assess that the
outcomes of such a trial been performed today could be
somewhat different.
The following considerations are important in interpret-
ing the long-term results of the OVER trial:
e The OVER trial supported that late aneurysm ruptures
can occur late (5 years) after EVAR. However,
according to OVER data, only six ruptures were recorded
during 4576 patient-years follow-up in patients assigned
to the EVAR group. The risk, even if apparently higher
than the 0 rate in the open surgery group, appears
clinically insigniﬁcant. Ruptures occurred in patients
who did not adhere to recommended follow-up (missed
follow-up or refused secondary therapeutic measures in
3 of 6) or in patients who were treated with old-
generation devices more likely to develop Type I
endoleak or other complications, no longer found with
modern devices. Of relevance, in the EVAR arm of the
OVER trial, the outdated AneuRx device was used in two
of three non-fatal ruptures and 6 of 10 patients with
aneurysm-related deaths. However, the overall AAA-
related death rate after EVAR, from perioperative period
up to 9 years, was only 2.3%. Based on these data, the
reassuring message from OVER is that EVAR is a safe
procedure also in the long term for patients compliant
with follow-up and treated with current generation
aortic stent graft.
e Concerns suggested by the OVER Authors regarding the
little beneﬁt of EVAR in older patients seem to be
unlikely, even though a non-signiﬁcant, higher all-cause
mortality risk in the long-term was shown for those 70
years ormore treated by EVAR compared to those treated
by open surgery (hazard ratio (HR) 1.31; P ¼ 0.06).1
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surgery can anticipate mortality in most of these more-
frail patients during the perioperative period (4.0% vs.
0.9%; P ¼ 0.03 in open vs. EVAR) leading to apparent
delayed increase in the rate of deaths related to suicide or
accident (P ¼ 0.01) or cardiovascular or pulmonary
causes in patients with more advanced age after EVAR, as
the OVER results showed.1
e OVER data suggest that EVAR can be used as an
effective treatment for AAA in younger patients
despite the expected length of follow-up after
treatment. Indeed, long-term durability of EVAR was
supported by the risk of secondary procedures, re-
hospitalisations and aneurysm-related deaths
comparable to open surgery. In addition, a non-
signiﬁcant beneﬁt in survival after EVAR (HR 0.65;
P ¼ 0.04) compared to open surgery was demonstrated
in younger patients.1
e Of relevance, the OVER showed decreased rates of
secondary procedures required after EVAR with
respect to those previously reported by other
randomised clinical trials (RCTs) comparing EVAR versus
open surgery.3,4 Differences in rates between the OVER
and the ACE (Anevrysme de l’aorte abdominale,
Chirurgie versus Endoprothese) trial3 or the EVAR 1
trial4 are likely due to an underestimation of the risk in
the open surgery group in the latter studies because
incisional hernias were not accounted for as secondary
procedures (see Table 1).
There are indeed two additional major issues that are
suggested by OVER late results:
e The presence of a number of aorto-iliac-relevant
abnormalities after surgery in the open surgery group
detected at the computed tomography (CT) scan
performed in the year preceding the end of the study
indicates that imaging follow-up cannot be disregarded
also after open repair of AAA. Both, open and EVAR
treatments, require careful surveillance.
e For the younger group of patients (<70 years) the
differential risk for all-cause mortality in long-term
favouring EVAR was mainly explained by the OVER
Authors as related to the higher cancer-related mortality
after open surgery (P ¼ 0.01).1 The high number of
cancer-related deaths raises doubts as to whether open
surgery repair might have accelerated, through an
unknown release of cytokines and inﬂammatory
mediators, an underlying neoplastic process anticipating
the last stadium of the cancer disease. Nevertheless,
while the decision to enrol in the trial about 18% of
patients with known neoplastic disease at baseline
might be debatable, additional data are needed to
support this hypothesis.
Table 1.
Trial Year N AAA Reinterventions P value Follow-up Type of reinterventions
EVAR Open
EVAR 14 2010 1252 > 5.5 cm 145/626b
5.1%a
10%c
55/626b
1.7%a
28%c
<0.001 6 years
median
Graft-related reinterventions.
Laparotomy-related complications such as incisional
hernia or wound infections were excluded.
DREAM5,d 2010 351 > 5 cm 29.6% 18.1% 0.03 6 years
6.4 years
median
Graft-related (e.g., thrombo-occlusive disease,
endoleak type 1 or endotension, endograft
migration, prosthesis infection, graft-material
failure, para-anastomotic aneurysm, and
aneurysm rupture); wound-related (e.g., incisional
hernia and wound infection); local or systemic
(e.g., bleeding, endoleak type 2, and ileus).
ACE3 2011 316 > 5 cm 16%b
23.9%c
2.7%b
14.2%c
<0.0001
0.01
3 years
median
Reinterventions for incisional repair not recorded.
Incisional complications: 0.7% in EVAR vs. 25.5%
in open; P < 0.0001.
OVER1 2012 881 > 5 cm 22.1%b 17.8%b 0.12 5.2 years
mean
Endovascular procedures, conversions to open repair,
open arterial procedures, wound-related procedures,
amputations, incisional hernia repairs, laparotomies
for bowel ischemia/obstruction, miscellaneous.
a Rate/100 person-yr.
b Crude rates.
c Cumulative rates.
d Including deaths and reinterventions at 3 years.
314 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 4 April/2013In conclusion, the results of the OVER trial remain of
utmost importance and the trial represents one of the very
few randomised investigations in the AAA space.3e5 The
long-term comparison of EVAR and open surgery for AAA
repair in the OVER trial shows comparability of the two
treatments in terms of both safety and durability with data
more reliable for the current practice with EVAR. Before
deciding upon one or the other treatment option for AAA,
careful discussion with the patient is essential. Post-repair
imaging cannot be missed also after open surgery to
preserve long-life safety.
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